IMATERO 400 MG FOR CHRONIC MYLEIOD LUKEMIA AND OTHER CANCER ‘S

Imatero 400 mg is a prescription anti-cancer medication containing Imatnib (as imatnib mesylate) . it is a target therapy https://oncomshealthcare.com/targeted-therapies-in-cancer-treatment-a-complete-guide/,specifically a tyrosine kinase inhibitor , used to treat chronic myeloid leukemia (CML), Gastrointestinal stromal tumors (GSIT) and other specific blood cancers by inhibiting the proteins that cause cancer cells to grow. It is used to treat certain types of leukemia ( cancer that begins in the white blood cells ) and other cancers and disorders of the blood cells.

WHAT IS IMATERO 400MG?

Imatero 400 mg tablet is a prescription anti-cancer (antineoplastic) medication categorized as a tyrosine kinase inhibitor. It contains the active ingredient Imatinib Mesylate, which is sed to treat specific blood cancers and gastrointestinal tumors (GIST) by blocking cancer cell growth.

Key classification :

  • Drug class: Tyrosine kinase inhibitor
  • Therapeutic class: Antineoplastic agent (Anti-cancer)
  • Active ingredient: imatinib mesylate 400 mg
  • Mechanism of action: inhibits the BCR-ABL tyrosine kinase enzyme , which reduces the proliferation of cancer cells and induces apoptosis (programmed cell death) .
  •  Indications: primarily treats Philadelphia chromosome-positive chronic myeloid leukemia and Gastrointestinal stromal tumors (GIST).

WHAT ARE THE MEDICAL USES OF IMATERO 400 MG TABLETS?

Medical uses of Imatero 400 MG tablets are:

1. Treatment of Chronic Myeloid leukemia

Imatero is a targated therapy used in treating chronic myeloid leukemia (CML) by inhibiting the BCR_ABL tryokinase enzyme that drives cancer cell growth. It is used as a standard treatment to help manage the condition and improve survival outcomes. It is often taken with food and a large glass of water to minimize gastric infection. Studies indicate that it is effective ,with 10 –year survival rates reported between 83-94% in some complete heamatological and cytogentic reponses.

2. Treatment of Gastrointestinal stromal tumors(GIST)

Imatero 400 mg is a tyrosine inhibitor commonly used to treat gastrointestinal stromal tumors (GIST) , a type of cancer that starts in the digestive tract . it act as a targeted therapy, inhibiting the BCR-ABL, KIT and PDGFRA proteins that promote cancer cell growth. It is used for unresectable , metastatic or adjuvant (post-surgery) treatment of KIT_ positive GIST. The standard dose is typically 400 mg per day. It significantly improves survival rate and delays progression in advanced GSIT.

3. Treatment of acute lymphoblastic leukemia (ALL)

Imatero is a tyrosine kinase inhibitor (TK) used in the treatment of Philadelphia chromosome –positive (PH+) acute Lymphoblastic Leukemia (ALL). It is a foundational targeted therapy for patients with PH+all ,which is characterized by the presence of Philadelphia chromosome (BCR-ABL fusion gene). It is generally used in the combination with chemotherapy during the induction and consolidation phases to improve complete remission rates.

WHAT ARE THE BENEFITS OF IMATERO 400 MG TABLETS?

BENEFITS OF IMAERTO 400 ARE:

1. Helps control cancer progression

Imatero is a targeted therapy designed to control progression by inhibiting the growth of abnormal cells. It works by blocking specific proteins, particularly the BCR-ABL tyrosine kinase, which tells cancer cells to grow and divide uncontrollably . it is primarily used to treat chronic myeloid leukemia (CML) and Gastrointestinal stromal tumors (GST) ,as well as certain types of acute lymphocytic Leukemia (ALL).

2. Reduces leukemia symptoms

Imatero 400 mg is a standard ,highly effective targeted therapy used to manage leukemia symptoms and progression ,particularly for chronic myleiod leukemia (CML). It works by blocking the BCR-ABL tyrosine kinase protein, which causes cancer cells to grow uncontrollably . studies show that a 400 mg daily dose provides excellent long-term results, with a 10 –year survival rate of approximately 83%for CML patients. It is a targeted therapy , not traditional chemotherapy ,which specifically inhibits cancer cell proliferation and induces cell death.

3. Supports long –term disease management

Imarteo 400 is designed for the long term management of specific, chronic blood and gastrointestinal cancers. It is a targated therapy used to control the disease, rather than cure it, by inhibiting the specific abnormal proteins responsible for cancer cell growth. It works as a tyrosine kinase inhibitor (TKI) to stop the growth and spread of abnormal cancer cells,often serving as the ‘’backbone’’ therapy for chronic myeloid leukemia .

WHAT ARE THE POSSIBLE SIDE EFFECTS OF IMATERO 400 MG?

Possible side effects of imatero 400 mg are:

1. Nausea and vomiting

Imatero 400 mg commonly causes nausea and vomiting often affecting 40% -50% of patients ,usually ranging from mild to moderate in severity. These side effects occur because of the medication impact on the gastrointestinal tract and are typically managed by taking the tablet with food and a glass of water.

2. Liver problems

Imatero 400 is used for cancer, but it can cause significant liver problems, including increased liver enzymes, (ALT/AST) ,hepotoxicity , and potential severe liver injury . while many asymptomatic elevation of liver enzymes is common, severe cases can lead to acute liver failure . imatero can cause acute liver injury (ALI), including severe hepatitis.

3. Severe low blood counts

Imatero 400 mg is a targated therapy that frequently causes severe, dose-dependent low blood counts including anemia, neutropenia, and thrombocytopenia. These conditions can occur within the first year of treatment and are often managed by monitoring blood counts and adjusting the dose.

CONCLUSION

Imatero 400 is a highly effective ,targated therapy for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) ,offering excellent long-term survival rates . it works by inhibiting specific tyrosine kinase proteins to stop cancer cell growth and proliferation.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: HOW LONG SHOULD TREATMENT CONTINUE?

Chronic myeloid leukemia treatment with targeted therapies is usually continued indefinitely ,often for years or decades, to manage cancer as a chronic condition . while many patients live a normal lifespan ,a small percentage may achieve a deep molecular response sustained for at least 2-5 years, allowing them to attempt treatment –free remission (TFR) under medical supervision .

QUESTION: CAN IMATERO BE TAKEN WITH OTHER MEDICATIONS?

Imatero has significant drug interactions and should generally not be taken with other medicens without strict medical supervision. It interacts with various prescription drugs , over the counter medications and herbal products ,which can increase side effects or reduce its effectiveness . always inform the doctor of all medications you are taking.

REFRENCES:

1)https://pharmeasy.in/online-medicine-order/metro-400mg-tablet-26731

2)https://www.medibuddy.in/order-medicines/metro-400mg-tablet-839170

Leave a Reply

Your email address will not be published. Required fields are marked *

Add to cart